Friday, July 10, 2026

pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma

Kyowa Kirin International

Kyowa Kirin International clinical programs — 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

GB HQ
1995 Founded
690 Employees
TGA registrant Type
Company details
Status
Public
HQ
GB
Founded
1995
Employees
690
Programs
15
Drugs
12
Patents
0
Intelligence · Clinical Programs

Kyowa Kirin International projects

15 ClinicalTrials.gov programs sponsored by Kyowa Kirin International.

Kyowa Kirin International has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. KHK4827

    KYOWA KIRIN AUSTRALIA PTY LTD

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule completed

    1 trial
  2. KW-6500

    KYOWA KIRIN AUSTRALIA PTY LTD

    Parkinson's Disease

    phase 3 small molecule completed

    1 trial
  3. OPC-262

    KYOWA KIRIN AUSTRALIA PTY LTD

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial
  4. AMG531

    KYOWA KIRIN AUSTRALIA PTY LTD

    Aplastic Anemia

    phase 2 small molecule completed

    1 trial
  5. Entinostat

    KYOWA KIRIN AUSTRALIA PTY LTD

    Advanced or Recurrent Breast Cancer

    phase 2 small molecule completed

    1 trial
  6. KHK7580

    KYOWA KIRIN AUSTRALIA PTY LTD

    Hyperparathyroidism

    phase 2 small molecule completed

    1 trial
  7. KW-2478

    KYOWA KIRIN AUSTRALIA PTY LTD

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial
  8. POTELIGEO 4 mg/mL concentrate for solution for infusion

    KYOWA KIRIN AUSTRALIA PTY LTD

    Mycosis fungoides/Sezary syndrome recurrent

    phase 2 small molecule active

    1 trial
  9. saxagliptin

    KYOWA KIRIN AUSTRALIA PTY LTD

    Diabetes, Type 2

    phase 2 small molecule completed

    1 trial
  10. 2223-001

    KYOWA KIRIN AUSTRALIA PTY LTD

    T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)

    phase 1 other active

    1 trial
  11. ARQ 197

    KYOWA KIRIN AUSTRALIA PTY LTD

    Advanced Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial
  12. KHK6640

    KYOWA KIRIN AUSTRALIA PTY LTD

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial
  13. KK8123

    KYOWA KIRIN AUSTRALIA PTY LTD

    X-linked hypophosphatemia.

    phase 1 small molecule active

    1 trial
  14. Placebo

    KYOWA KIRIN AUSTRALIA PTY LTD

    Healthy Volunteers Essential Hypertension

    phase 1 small molecule active

    1 trial
  15. Placebo

    KYOWA KIRIN AUSTRALIA PTY LTD

    Healthy

    other active

    1 trial

Frequently asked questions

How many clinical projects does Kyowa Kirin International have?

15 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.